YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (01558) said its profit and total comprehensive income attributable to equity shareholders of the company was RMB968.42 million for the six months ended 30 June 2019, a year-on-year increase of 52.62%. The earnings per share were RMB2.15. An interim dividend of RMB1 will be distributed.
The revenue was RMB3.07 billion, a year-on-year increase of 107.18%. The gross profit was RMB2.62 billion, a year-on-year increase of 110.77%.
全新節目《說說心理話》青少年不可以戀愛！？真實個案講述驚心動魄經歷► 即睇
